Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 20, 2011
- Revision received November 10, 2011
- Accepted November 11, 2011
- Published online December 31, 2011.
Copyright & Usage
Copyright© 2012 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- Thomas Wiedl1,2,*,
- Stéphane Collaud1,*,
- Sven Hillinger1,
- Stephan Arni1,
- Chris Burgess3,
- Werner Kroll3,
- Peter Schraml1,
- Alex Soltermann1,
- Holger Moch1 and
- Walter Weder1
- 1 Division of Thoracic Surgery, Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland
- 2 Cancer Biology PhD Program, Life Science Zurich Graduate School, ETH Zurich and University of Zurich, Zurich, Switzerland
- 3 Novartis Institutes for BioMedical Research Inc., Cambridge, MA, U.S.A.
- Correspondence to: Thomas Wiedl, Division of Thoracic Surgery, University Hospital Zurich, Raemistrasse 100, CH-8091 Zurich, Switzerland. Tel: +41 0442558802, Fax: +41 0442558805, e-mail: thomas.wiedl{at}yahoo.com
Cited By...
In this issue
KRAS Mutation Is Associated with Elevated Myeloblastin Activity in Human Lung Adenocarcinoma
Jump to section
Related Articles
Cited By...
- No citing articles found.